RISK FACTORS AND CLINICAL CONSEQUENCES OF OSTEOPOROSIS IN POSTMENOPAUSEOUS WOMEN

Authors

  • Daniela Dobrovoljski University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina
  • Duška Jović University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina
  • Darija Knežević University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina
  • Vlastimir Vlatković University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina
  • Ivona Risović University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina

Keywords:

osteoporosis, postmenopause, risk factors, fracture

Abstract

Osteoporosis (OP) is the most common metabolic disease of modern times, characterized by a decrease in bone density and a disruption of bone microarchitecture, which makes the bone prone to fractures, either spontaneously or with a force that is less than that normally required to fracture a healthy bone. It mainly affects women, less often men, and the most common is the so-called postmenopausal osteoporosis, which occurs as a result of a decrease in the female sex hormone estrogen.
The aim of this study is to determine the presence of risk factors for the development of osteoporosis in relation to the menopause period and the occurrence of fractures, as possible complications.
The research was conducted as a cross-sectional clinical study, conducted at the Department of Rheumatology of the University Clinical Center of the Republic of Srpska (UKC RS) during 2023. The study included 101 female subjects in menopause, with osteoporosis, with or without fracture, with an average age of 64.58 years (SD = 7.39). The collected data were analyzed using descriptive statistics, where the average values (M) and standard deviations (SD), minimum and maximum values, frequencies and percentages were calculated, and the distributions of the results were presented graphically. Statistical processing was performed in the IBM SPSS Statistics 21 software package. Results with a reliability of р<0.05 were considered statistically significant.
Osteoporosis was present in all patients in the study, most of whom lived in urban areas, the average age of menopause was 51 years, and osteoporosis occurred on average at 54 years. Fractures were more common in subjects with significantly reduced bone density, in the lumbar spine, with one third having a fracture and 3.96% having more than one fracture. The differences in distribution were statistically significant (p < 0.01). Hip fracture, the most severe clinical manifestation of osteoporosis, was found in 6.5% of subjects, with high statistical significance.
The association between menopause and the occurrence of osteoporosis has been established, and the importance of systematic monitoring of risk factors for preserving bone health in postmenopausal women has been established.
Educate women about the importance of a healthy lifestyle, with an emphasis on regular physical activity and the importance of a diet rich in nutrients important for bone health. Implement educational programs on the prevention of falls and fractures, as well as provide psychological support to women who already have osteoporosis, with the aim of preserving quality of life.

Author Biographies

Daniela Dobrovoljski, University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina

University Clinical Center of Republika Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina

Vlastimir Vlatković, University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina

University Clinical Center of Republika Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina

Ivona Risović, University of Banja Luka, Faculty of Medicine, Banja Luka, Republika Srpska, Bosnia and Herzegovina

University Clinical Center of Republika Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina

References

Amarnath S.S, Kumar V, & Lakshmana S.D. (2023). Classification of osteoporosis. Indian Journal of Orthopaedics, 57(Suppl 1), 49–54. https://doi.org/10.1007/s43465-023-01058-3

Amirkhizi F, Hamedi-Shahraki S, & Rahimlou M. (2023). Dietary total antioxidant capacity is associated with lower disease severity and inflammatory and oxidative stress biomarkers in patients with knee osteoarthritis. J Health Popul Nutr. 42:104. https://doi.org/10.1186/s41043-023-00450-x

Berry, S. D., Lee, Y., Zullo, A. R., Kiel, D. P., Dosa, D., & Mor, V. (2016). Incidence of hip fracture in the U.S. The Journals of Gerontology: Series A, Biological Sciences and Medical Sciences, 71(9), 1230–1234. https://doi.org/10.1093/gerona/glw034

Body JJ, Marin F, Kendler DL, Zerbini CAF, López-Romero P, Möricke R, Casado E, Fahrleitner-Pammer A, Stepan JJ, Lespessailles E, Minisola S, & Geusens P. (2020). Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial Osteoporos Int. 31(10):1935-1942. https://doi.org/10.1007/s 00198-020-05463-4.

Bošković K, Protić B, Grajić M, Madić D, Obradović B, & Tomašević-Todorović S. (2013). Adapted Physical Activity in the Prevention and Therapy of Osteoporosis. Medicinski pregled. Volume 66, Issue 5-6, Pages: 221-224 https://doi.org/10.2298/MPNS1306221B

Dimai H.P. (2017). Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment: WHO criteria, T- and Z-score, and reference databases. Bone, 104, 39–43. https://doi.org/10.1016/j.bone.2016.12.016

Gur A, Sarac A.J, Nas K, & Cevik R. (2004). The relationship between educational level and bone mineral density in postmenopausal women. BMC Family Practice, 5, 18. https://doi.org/10.1186/1471-2296-5-18

Hakur R. (2014). Lifestyle and dietary factors determine age at natural menopause. Journal of Mid-Life Health, 5(3). https://doi.org/10.4103/0976-7800.127779

Johansson L, Johansson H, & Axelsson K.F. (2022). Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX. Osteoporosis International, 33, 1725–1738. https://doi.org/10.1007/s00198-022-06387-x

Khinda R, Valecha S, Kumar N, Walia J.P.S, Singh K, Sethi S, Singh A, Singh M, Singh P, & Mastana S. (2022). Prevalence and predictors of osteoporosis and osteopenia in postmenopausal women of Punjab, India. International Journal of Environmental Research and Public Health, 19(5), 2999. https://doi.org/10.3390/ijerph19052999

Merle B, Dupraz C, Haesebaert J, Barraud L, Aussedat M, Motteau C, Simon V, Schott A.M, & Flori M. (2019). Osteoporosis prevention: Where are the barriers to improvement in a French general population? A qualitative study. Osteoporosis International, 30(1), 177–185. https://doi.org/10.1007/s00198-018-4720-5

Punda M, & Grazio S. (2014). Denzitometrija skeleta – zlatni standard za dijagnozu osteoporoze. Reumatizam, 61(2), 70–74. https://hrcak.srce.hr/137901

Ramírez-Pérez E, Clark P, Barredo-Prieto B, Casas-Ávila L, Diez-García M.A, & Valdés-Flores M. (2019). Comparative study. Cirugía y Cirujanos, 87(3), 260–266. https://doi.org/10.24875/CIRU.19000406

Ratajczak A.E, Rychter A.M, Zawada A, Dobrowolska A, & Krela-Kaźmierczak I. (2020). Nutrients in the prevention of osteoporosis in patients with inflammatory bowel diseases. Nutrients, 12(6), 1702. https://doi.org/10.3390/nu12061702

Rodgers R.J, & Laven J.S. (2020). Genetic relationships between early menopause and the behaviour of theca interna during follicular atresia. Human Reproduction, 35(10), 2185–2187. https://doi.org/10.1093/humrep/deaa173

Silva BC, & Hipólito Rodrigues MA. (2023). Estrogen hormone therapy and postmenopausal osteoporosis: does it really take two to tango? Women Health. 63(10):770–3. https://doi.org/10.1080/03630242.2023.2278211

Sözen T, Özışık L, & Başaran N.Ç. (2017). An overview and management of osteoporosis. European Journal of Rheumatology, 4(1), 46–56. https://doi.org/10.5152/eurjrheum.2016.048

Šimunić V, & Jeren L. (2002). Patofiziologija menopauze i novije kliničke spoznaje o klimakteriju i postmenopauzi. U Klimakterij i postmenopauza, hormonsko nadomjesno liječenje (str. 183). Zagreb: FotoSoft. ISBN 953-7064-00-X

Vukosavljević J, Simić G, & Vukosavljević I. (2014). Osteoporoza u primarnoj zdravstvenoj zaštiti – tiha epidemija. PONS Medicalis Časopis, 11, 72–77. https://doi.org/10.5937/pomc11-6527

Wang P, Abdin E, Shafie S, Chong S.A, Vaingankar J.A, & Subramaniam M. (2019). Estimation of prevalence of osteoporosis using OSTA and its correlation with sociodemographic factors, disability and comorbidities. International Journal of Environmental Research and Public Health, 16(13), 2338. https://doi.org/10.3390/ijerph16132338

Wang Y, Ding H, Wang X, Wei Z, & Feng S. (2019). Associated factors for osteoporosis and fracture in Chinese elderly. Medical Science Monitor, 25, 5580–5588. https://doi.org/10.12659/MSM.914182

Watts N.B. (2014). Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Nature Reviews Endocrinology, 10, 412–422. https://doi.org/10.1038/nrendo.2014.55

Zvekić-Svorcan J, Mikloš M, Filipović K, Vuksanović M, & Aleksić J. (2018). Social and mental functioning in postmenopausal women with low bone mineral density. Medicinski Pregled, LXXI(5–6), 171–179. https://doi.org/10.2298/MPNS1806171Z

Downloads

Published

2026-02-13

How to Cite

Dobrovoljski, D., Jović, D., Knežević, D., Vlatković, V., & Risović, I. (2026). RISK FACTORS AND CLINICAL CONSEQUENCES OF OSTEOPOROSIS IN POSTMENOPAUSEOUS WOMEN. KNOWLEDGE - International Journal , 74(4), 475–482. Retrieved from https://ojs.ikm.mk/index.php/kij/article/view/8120